Royalty Pharma co-founder and chairman Rory Biggs. The US-based company has withdrawn its hostile bid for Irish drugmaker Elan.

MARY CAROLAN Royalty Pharma has withdrawn its court challenge to the Irish Takeover Panel’s decision requiring Royalty to lapse or withdraw its US$8 b(...)

Elan chairman Robert Ingram at the company’s EGM in Dublin today. Photograph: Aidan Crawley

Elan shareholders decisively rejected a major investment programme proposed by the company at a special meeting in Dublin today.However, investors nar(...)

One minute, Elan’s suitor, Royalty Pharma, was warning it might be forced to walk away as shareholders appeared certain to back a proposal by the Iris(...)

Elan shareholders vote on four proposed investments by the company at an EGM on Monday.Photographer: Dara Mac Dónaill

A High Court judge has granted an injunction effectively keeping alive Royalty Pharma’s $6.7 billion offer for Elan pending the outcome of a full lega(...)

Royalty Pharma is looking to ensure its bid for Elan remains open even if some resolutions are passed by shareholders at EGM.  Photograph: Bryan O’Brien

Dublin-based fund Royalty Pharma has moved to fast-track its legal challenge to decisions by the Irish Takeover Panel that its $6.7 billion offer for (...)

Royalty said it was concerned the takeover panel’s ruling would “deprive” Elan shareholders of the chance to consider its improved offer of $13 a share. Photographer: John Cogill/Bloomberg News

Royalty Pharma has challenged a decision by the Irish Takeover Panel that it will have to lapse (withdraw) its $6.7 billion offer for Elan if any of f(...)

The Elan plant in Athlone, Co Westmeath. Latest revised bid brings the Royalty offer very much into the realm that Elan says accurately represents the fair value of the company.  Photographer: Dara MacDonaill/The Irish Times

Royalty Pharma tightened the squeeze on Elan yesterday with a second revised offer just hours after diclosing its had secured the support of holders o(...)

 Elan chief executive Kelly Martin. Photograph: Alan Betson

A legal action by pharmaceutical firm Elan aimed at stopping Royalty Pharma distributing a statement to Elan’s shareholders is not proceeding, the Hig(...)

Robert Ingram, chairman of Elan with Kelly Martin, CEO. Photograph: David Sleator

Royalty Pharma must make an offer for Elan by May 10th or announce it will not proceed, the Irish Takeover Panel said yesterday. The deci(...)